Sorrenti Vincenzo, Benedetti Francesca, Buriani Alessandro, Fortinguerra Stefano, Caudullo Giada, Davinelli Sergio, Zella Davide, Scapagnini Giovanni
Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Largo Egidio Meneghetti, 2, 35131 Padova, Italy.
Bendessere® Study Center, Via Prima Strada 23/3, 35129 Padova, Italy.
Pharmaceuticals (Basel). 2022 Jul 23;15(8):912. doi: 10.3390/ph15080912.
Aging results from the progressive dysregulation of several molecular pathways and mTOR and AMPK signaling have been suggested to play a role in the complex changes in key biological networks involved in cellular senescence. Moreover, multiple factors, including poor nutritional balance, drive immunosenescence progression, one of the meaningful aspects of aging. Unsurprisingly, nutraceutical and pharmacological interventions could help maintain an optimal biological response by providing essential bioactive micronutrients required for the development, maintenance, and the expression of the immune response at all stages of life. In this regard, many studies have provided evidence of potential antiaging properties of resveratrol, as well as rapamycin and metformin. Indeed, in vitro and in vivo models have demonstrated for these molecules a number of positive effects associated with healthy aging. The current review focuses on the mechanisms of action of these three important compounds and their suggested use for the clinical treatment of immunosenescence and aging.
衰老源于多种分子途径的渐进性失调,mTOR和AMPK信号传导被认为在参与细胞衰老的关键生物网络的复杂变化中发挥作用。此外,包括营养失衡在内的多种因素推动免疫衰老进程,这是衰老的一个重要方面。不出所料,营养保健品和药物干预可以通过提供生命各阶段免疫反应的发育、维持和表达所需的必需生物活性微量营养素,来帮助维持最佳生物反应。在这方面,许多研究提供了白藜芦醇、雷帕霉素和二甲双胍具有潜在抗衰老特性的证据。事实上,体外和体内模型已经证明这些分子具有许多与健康衰老相关的积极作用。本综述重点关注这三种重要化合物的作用机制及其在免疫衰老和衰老临床治疗中的建议用途。